1808287-83-3

1808287-83-3 structure

Name: CHMFL-ABL-053
Chemical Name: 2-[(3-Amino-4-methylphenyl)amino]-4-(methylamino)-N-(2-methyl-5-{[3-(trifluoromethyl)benzoyl]amino}phenyl)-5-pyrimidinecarboxamide
CAS Number: 1808287-83-3
Molecular Formula: C₂₈H₂₆F₃N₇O₂
Molecular Weight: 549.547
Catalog: Signaling Pathways MAPK/ERK Pathway p38 MAPK
Create Date: 2020-01-12 11:13:51
Modify Date: 2024-04-06 15:41:04
CHMFL-ABL-053 is a potent, selective and orally available Bcr-Abl/Src/p38 kinase inhibitor with IC50 of 70/62/90 nM; no inhibitory activity against c-Kit (>10 uM); inhibits the proliferation of CML cell lines K562 (GI50=14 nM), KU812 (GI50=25 nM), and MEG-01 (GI50=16 nM); completely suppresses tumor progression in the K562 cells inoculated xenograft mouse model with 50 mg/kg/day dosage treatment.

Name	2-[(3-Amino-4-methylphenyl)amino]-4-(methylamino)-N-(2-methyl-5-{[3-(trifluoromethyl)benzoyl]amino}phenyl)-5-pyrimidinecarboxamide
Synonyms	5-Pyrimidinecarboxamide, 2-[(3-amino-4-methylphenyl)amino]-4-(methylamino)-N-[2-methyl-5-[[3-(trifluoromethyl)benzoyl]amino]phenyl]- 2-[(3-Amino-4-methylphenyl)amino]-4-(methylamino)-N-(2-methyl-5-{[3-(trifluoromethyl)benzoyl]amino}phenyl)-5-pyrimidinecarboxamide

Description	CHMFL-ABL-053 is a potent, selective and orally available Bcr-Abl/Src/p38 kinase inhibitor with IC50 of 70/62/90 nM; no inhibitory activity against c-Kit (>10 uM); inhibits the proliferation of CML cell lines K562 (GI50=14 nM), KU812 (GI50=25 nM), and MEG-01 (GI50=16 nM); completely suppresses tumor progression in the K562 cells inoculated xenograft mouse model with 50 mg/kg/day dosage treatment.
References	References 1. Liang X, et al. J Med Chem. 2016 Mar 10;59(5):1984-2004. View Related Products by Target Bcr-Abl